IDH3A and central nervous system cancer: Isocitrate dehydrogenase, 1p/19q, and MGMT promoter methylation are three important features reported to serve as prognostic indicators for gliomas (5), with IDH-wt and IDH-mutant are two WHO classifications for GBM (6).